You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

basal insulin

Showing 1 - 25 of 9,580
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Charlottesville (Control-IQ use in Type 2 Diabetes under basal insulin injections)

Not yet recruiting
  • Type 2 Diabetes
  • Control-IQ use in Type 2 Diabetes under basal insulin injections
  • Charlottesville, Virginia
    University of Virginia Center for Diabetes Technology
Sep 5, 2023

Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

Recruiting
  • Diabetes Mellitus, Type 2 Treated With Insulin
  • insulin degludec + liraglutide
  • Insulin Glargine - Insulin Aspart
  • Bogotá, Colombia
    Hospital Universitario San Ignacio
Mar 2, 2023

Type 2 Diabetes Trial in New York, Charlottesville (Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in

Not yet recruiting
  • Type 2 Diabetes
  • Continuous Glucose Monitoring (CGM)-based titration algorithm implemented in DiAs
  • New York, New York
  • +1 more
Nov 2, 2023

Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • INS068 injection
  • Insulin Glargine
  • (no location specified)
Jan 19, 2023

Diabetes, Type 1 Trial (Afrezza, insulin degludec, Rapid-acting Insulin Analog)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Afrezza
  • +3 more
  • (no location specified)
Jun 6, 2023

Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin

Not yet recruiting
  • Type2diabetes
  • Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
  • +2 more
  • Nasiriyah, Thi Qar, Iraq
  • +1 more
Oct 28, 2023

Diabetes, Type 2 Trial (Empagliflozin 25 MG, INS)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Empagliflozin 25 MG
  • INS
  • (no location specified)
Jul 19, 2022

Type 2 Diabetes Trial in Cleveland (Semaglutide, Insulin Degludec, Insulin aspart)

Recruiting
  • Type 2 Diabetes
  • Cleveland, Ohio
    Cleveland Clinic
Jul 18, 2022

Diabetic Ketoacidosis, Type 1 Diabetes, Type 2 Diabetes Trial in Cleveland (Early Glargine, Late Glargine, IV insulin infusion)

Terminated
Has Results
  • Diabetic Ketoacidosis
  • +2 more
  • Early Glargine
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Fairview Hospital
Aug 1, 2022

Persistence to Basal Insulin in Type 2 Diabetes

Not yet recruiting
  • Type 2 Diabetes Mellitus (T2DM)
    • Chilly-Mazarin, France
      Investigational Site Number :
    Nov 16, 2022

    Insulia® Tool in Type 2 Diabetes Treated With Basal Insulin

    Recruiting
    • Type 2 Diabetes Mellitus
      • Corbeil-essonnes Cedex, France
        Centre Hospitalier Sud Francilien
      Nov 21, 2022

      to Identify Which Titration Regimen of Basal Insulin (Being Daily Titration vs 3 Daily Titration) is Better in Reducing hba1c

      Recruiting
      • to Identify Which Titration Regimen of Basal Insulin (Being Daily Titration vs 3 Daily Titration) is Better in Reducing hba1c and Have Lesser Hypoglycemia
      • NPH basal insulin titration
      • Kuala Lumpur, Malaysia
        University Malaya Medical Centre
      Apr 11, 2022

      Type 2 Diabetes Trial (Connected Solution with H2S app which connects with blood glucose meter (BGM))

      Not yet recruiting
      • Type 2 Diabetes Mellitus
      • Connected Solution with H2S app which connects with blood glucose meter (BGM)
      • (no location specified)
      Jan 12, 2023

      Type 1 Diabetes Trial in Charlottesville (Basal insulin alone, Basal pramlintide and reduced basal insulin, CGM)

      Terminated
      • Type 1 Diabetes Mellitus
      • Basal insulin alone
      • +5 more
      • Charlottesville, Virginia
        University of Virginia Center for Diabetes Technology
      Mar 10, 2022

      Type 1 Diabetes Trial (Semaglutide weekly injection)

      Not yet recruiting
      • Type 1 Diabetes
      • Semaglutide weekly injection
      • (no location specified)
      Sep 21, 2023

      Hyperglycaemic Crisis in Diabetes, Diabetic Ketoacidosis, Hyperglycaemic Hyperosmolar Nonketotic Syndrome Trial in Changhua city

      Recruiting
      • Hyperglycaemic Crisis in Diabetes Mellitus
      • +2 more
      • Insulin Glargine 300 UNT/ML [Toujeo]
      • Changhua city, Taiwan
        Changhua Christian Hospital
      Mar 8, 2022

      Glycaemic Control and Other Clinical Parameters in Adult Type 2

      Completed
      • Diabetes Mellitus, Type 2
      • Medellín, Antioquia, Colombia
      • +5 more
      Nov 4, 2022

      Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy

      Active, not recruiting
      • Diabetes Mellitus Type 2 - Insulin-Treated
      • Smartphone application and web portal
      • Standard Insulin Therapy Education
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Medical Center
      Jan 6, 2023

      Diabetes, Type 2 Trial in United Kingdom (FreeStyle Libre 3 Continuous Glucose Monitoring System., Self monitoring of blood

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • FreeStyle Libre 3 Continuous Glucose Monitoring System.
      • Self monitoring of blood glucose
      • Birmingham, United Kingdom
      • +16 more
      Jul 12, 2023

      Type 1 Diabetes Trial in Montreal (Continous exercise, Interval exercise, Reduction of basal insulin by 40%)

      Recruiting
      • Type 1 Diabetes Mellitus
      • Continous exercise
      • +3 more
      • Montreal, Quebec, Canada
      • +1 more
      Jan 12, 2022

      Type 2 Diabetes, Type 2 Diabetes Treated With Insulin Trial in Boston (Basal Insulin)

      Withdrawn
      • Type 2 Diabetes
      • Type 2 Diabetes Treated With Insulin
      • Basal Insulin
      • Boston, Massachusetts
        Boston Medical Center
      Aug 18, 2021

      s and Activity Data in Type 2 Diabetes on Different Treatments

      Not yet recruiting
      • Diabetes Mellitus, Type 2
      • Lifestyle
      • +4 more
      • (no location specified)
      Sep 16, 2022

      Diabetes, Type 2 Trial in Minneapolis, Berlin, Toronto (4 mm x 32G pen needle (Nano), 8mm x 31G pen needle (Short))

      Terminated
      Has Results
      • Diabetes Mellitus, Type 2
      • 4 mm x 32G pen needle (Nano)
      • 8mm x 31G pen needle (Short)
      • Minneapolis, Minnesota
      • +2 more
      Feb 28, 2022

      Type 1 Diabetes Trial in Bobo-Dioulasso, Ouagadougou (premix insulin human isophane suspension and insulin human, Humulin N plus

      Not yet recruiting
      • Type 1 Diabetes
      • premix insulin human isophane suspension and insulin human
      • Humulin N plus Humulin R
      • Bobo-Dioulasso, Houet, Burkina Faso
      • +2 more
      Mar 12, 2023

      Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

      Completed
      • Type 2 Diabetes Mellitus
      • INSULIN GLARGINE (HOE901)
      • +5 more
      • China, China
        CHINA
      Apr 21, 2022